Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Pozycja w akcjach #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Cena akcji
$0.05137558
Ostatnia synchronizacja: 2026-08-13
Kapitalizacja rynkowa
$1.88M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-11.66%
Kraj
CA
Handel Restart Life Sciences Corp. (HEAL)

Kategoria

Historia stopy dywidendy dla Restart Life Sciences Corp. (HEAL)
Stopa dywidendy (TTM) dla Restart Life Sciences Corp. (symbol akcji: HEAL) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Restart Life Sciences Corp. (HEAL) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji